256 related articles for article (PubMed ID: 20458565)
1. The use of biorelevant dissolution media to forecast the in vivo performance of a drug.
Klein S
AAPS J; 2010 Sep; 12(3):397-406. PubMed ID: 20458565
[TBL] [Abstract][Full Text] [Related]
2. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
3. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
Jones HM; Parrott N; Ohlenbusch G; Lavé T
Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
[TBL] [Abstract][Full Text] [Related]
4. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
5. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
[TBL] [Abstract][Full Text] [Related]
6. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
7. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
8. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
9. Current methods for predicting human food effect.
Lentz KA
AAPS J; 2008 Jun; 10(2):282-8. PubMed ID: 18500565
[TBL] [Abstract][Full Text] [Related]
10. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data.
Nicolaides E; Galia E; Efthymiopoulos C; Dressman JB; Reppas C
Pharm Res; 1999 Dec; 16(12):1876-82. PubMed ID: 10644077
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
[TBL] [Abstract][Full Text] [Related]
12. Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.
Mathias N; Xu Y; Vig B; Kestur U; Saari A; Crison J; Desai D; Vanarase A; Hussain M
AAPS J; 2015 Jul; 17(4):988-98. PubMed ID: 25933598
[TBL] [Abstract][Full Text] [Related]
13. Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects.
Parrott N; Lukacova V; Fraczkiewicz G; Bolger MB
AAPS J; 2009 Mar; 11(1):45-53. PubMed ID: 19184451
[TBL] [Abstract][Full Text] [Related]
14. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
15. Potential prediction of formulation performance in paediatric patients using biopharmaceutical tools and simulation of clinically relevant administration scenarios of nifedipine and lorazepam.
Van der Vossen AC; Hanff LM; Vulto AG; Fotaki N
Br J Clin Pharmacol; 2019 Aug; 85(8):1728-1739. PubMed ID: 30964947
[TBL] [Abstract][Full Text] [Related]
16. In-vitro-in-silico investigation of the negative food effect of zolpidem when administered as immediate-release tablets.
Paraiso RLM; Watanabe A; Andreas CJ; Turner D; Zane P; Dressman J
J Pharm Pharmacol; 2019 Nov; 71(11):1663-1676. PubMed ID: 31566757
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests.
Yamaguchi Ikeuchi S; Kambayashi A; Kojima H; Oku N; Asai T
Biol Pharm Bull; 2018; 41(11):1708-1715. PubMed ID: 30381671
[TBL] [Abstract][Full Text] [Related]
18. Fed-state gastric media and drug analysis techniques: Current status and points to consider.
Baxevanis F; Kuiper J; Fotaki N
Eur J Pharm Biopharm; 2016 Oct; 107():234-48. PubMed ID: 27422208
[TBL] [Abstract][Full Text] [Related]
19. [The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo].
Ramenskaia GV; Shokhin IE; Savchenko AIu; Volkova EA
Biomed Khim; 2011; 57(5):482-9. PubMed ID: 22629598
[TBL] [Abstract][Full Text] [Related]
20. Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms.
Otsuka K; Shono Y; Dressman J
J Pharm Pharmacol; 2013 Jul; 65(7):937-52. PubMed ID: 23738721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
